Affordable Access

Different effects on oestrogen binding sites and anti-oestrogenic action of danazol and progesterone.

Authors
  • Tamaya, T
  • Wada, K
  • Mori, H
  • Imai, A
Type
Published Article
Journal
Annals of clinical biochemistry
Publication Date
May 01, 1991
Volume
28 ( Pt 3)
Pages
250–252
Identifiers
PMID: 1872570
Source
Medline
License
Unknown

Abstract

Rabbit uterus contains type I and II oestrogen binding sites in the cytosol, and nuclear fractions. Oestrogen-stimulated increase in uterine weight was inhibited by concurrent treatment with progesterone or danazol. Oestrogen-induced type I binding sites were decreased by progesterone and to a lesser extent by danazol, while oestrogen-induced type II sites were decreased almost equally in the two groups. Neither progesterone nor danazol alone caused any detectable changes in uterine weight. These findings may suggest that the anti-oestrogenic effect on uterine weight is more correlated with the change in type II binding sites of oestrogen than that in type I sites. Thus, danazol may exert anti-oestrogenic actions through a pathway independent from that of progesterone.

Report this publication

Statistics

Seen <100 times